1. Home
  2. MRVI vs IRMD Comparison

MRVI vs IRMD Comparison

Compare MRVI & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$7.72

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo iRadimed Corporation

IRMD

iRadimed Corporation

HOLD

Current Price

$87.61

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRVI
IRMD
Founded
2014
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
MRVI
IRMD
Price
$7.72
$87.61
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$4.13
$116.00
AVG Volume (30 Days)
4.0M
108.2K
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
0.95%
EPS Growth
14.29
16.67
EPS
N/A
0.86
Revenue
$185,743,000.00
$83,814,000.00
Revenue This Year
$12.54
$12.38
Revenue Next Year
$7.87
$11.31
P/E Ratio
N/A
$101.16
Revenue Growth
N/A
14.43
52 Week Low
$2.29
$67.84
52 Week High
$9.42
$107.90

Technical Indicators

Market Signals
Indicator
MRVI
IRMD
Relative Strength Index (RSI) 60.70 41.27
Support Level $5.37 $84.05
Resistance Level N/A $88.72
Average True Range (ATR) 0.51 2.33
MACD 0.20 0.09
Stochastic Oscillator 63.37 32.47

Price Performance

Historical Comparison
MRVI
IRMD

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

About IRMD iRadimed Corporation

iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.

Share on Social Networks: